Proton Pump Inhibitors in Geriatric and Hospice Populations: Balancing Benefit and Burden
Proton pump inhibitors (PPIs) are among the most commonly prescribed medications worldwide. While their short-term efficacy in managing acid-related disorders is well established, their long-term use—especially in older adults and hospice patients—raises important concerns about safety, necessity, and alignment with patient-centered goals of care. As palliative and hospice